Anthrax X-rayed: new opportunities for biodefence

Author： Stubbs M.T.  

Publisher： Elsevier

ISSN： 0165-6147

Source： Trends in Pharmacological Sciences, Vol.23, Iss.12, 2002-12, pp. : 539-541

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

New Developments in Vaccines, Inhibitors of Anthrax Toxins, and Antibiotic Therapeutics for Bacillus anthracis

By  

Current Medicinal Chemistry, Vol. 18, Iss. 33, 2011-11 ,pp. : 5083-5094

Bentham Science Publishers

Access to resources Recommend Favorite

The UK's new layer of prescribers brings new opportunities

By  

PharmacoEconomics and Outcomes News, Vol. 1, Iss. 407, 2003-01 ,pp. : 3-4

Adis International

Access to resources Recommend Favorite

New Opportunities for Pregnane X Receptor (PXR) Targeting in Drug Development. Lessons from Enantio- and Species-Specific PXR Ligands Identified from A Discovery Library of Amino Acid Analogues

By  

Mini Reviews in Medicinal Chemistry, Vol. 7, Iss. 6, 2007-06 ,pp. : 617-625

Bentham Science Publishers

Access to resources Recommend Favorite

Improving the Development on New Cancer Treatments: Challenges and Opportunities

By  

Drug Design Reviews - Online, Vol. 2, Iss. 5, 2005-08 ,pp. : 341-348

Bentham Science Publishers

Access to resources Recommend Favorite

Melanocortin receptors: new opportunities in drug discovery

By Wikberg J.E.  

Expert Opinion on Therapeutic Patents, Vol. 11, Iss. 1, 2001-01 ,pp. : 61-76

Informa Healthcare

Access to resources Recommend Favorite